Use of open access platforms for clinical trial data

JAMA - Journal of the American Medical Association

Volumn 315, Issue 12, 2016, Pages 1283-1284

  Navar, Ann Marie ^a   Pencina, Michael J ^a   Rymer, Jennifer A ^a   Louzao, Darcy M ^a   Peterson, Eric D ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACCESS TO INFORMATION; CLINICAL RESEARCH; CLINICAL TRIAL (TOPIC); HUMAN; INTERNET; LETTER; OPEN ACCESS PUBLISHING; PRIORITY JOURNAL; PUBLICATION; DRUG INDUSTRY; FACTUAL DATABASE; INFORMATION DISSEMINATION; STATISTICS AND NUMERICAL DATA;

ACCESS TO INFORMATION; CLINICAL TRIALS AS TOPIC; DATABASES, FACTUAL; DRUG INDUSTRY; HUMANS; INFORMATION DISSEMINATION;

EID: 84962259610     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.2016.2374     Document Type: Letter

References (5)

1. Krumholz HM, Peterson ED. Open access to clinical trials data. JAMA. 2014; 312(10):1002-1003.
2. The YODA Project. The YODA Project website. http://yoda.yale.edu. Accessed January 26, 2016.
3. ClinicalStudyDataRequest.com. ClinicalStudyDataRequest.com website. https://clinicalstudydatarequest.com/. Accessed January 26, 2016.
4. Pencina MJ, Louzao DM, McCourt BJ, et al. Supporting open access to clinical trial data for researchers: the Duke Clinical Research Institute-Bristol-Myers Squibb Supporting Open Access to Researchers Initiative. Am Heart J. 2016;172:64-69.
5. Le Noury J, Nardo JM, Healy D, et al. Restoring Study 329: efficacy and harms of paroxetine and imipramine in treatment of major depression in adolescence. BMJ. 2015;351:h4320.